Nuwellis, Inc. (NUWE) Stock

Nuwellis, Inc. (NUWE) is a Healthcare stock trading at $0.13 (as of 2026-06-18), with a market capitalization of $1.64M and a trailing P/E of -0.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Nuwellis, Inc. develops, manufactures, and commercializes medical devices for ultrafiltration therapy, including the Aquadex FlexFlow and Aquadex SmartFlow systems used to treat patients with fluid overload who have not responded to diuretics. The company sells through a direct sales team in the United States and via independent specialty distributors internationally to hospitals and clinics.

Valuation — source: SEC EDGAR (first-party)
Price	$0.13
Market Cap	$1.64M
P/E Ratio	-0.0
EV / EBITDA	0.0
Price / Book	0.78
Price / Sales	0.24
DCF Value (model)	$-79.80
DCF Upside vs Price	-59298.8%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$8.27M
Net Margin	-211.9%
Return on Equity	-715.8%
Current Ratio	1.56
Revenue Growth (YoY)	-5.4%
EPS Growth (YoY)	201.9%
FCF Growth (YoY)	12.9%

Financial Health — source: SEC EDGAR
Altman Z-Score	-76.54 (distress)

Valuation vs Sector & Industry
Stock P/E	-0.0
Sector P/E (Healthcare)	20.9
Industry P/E (Medical Equipment)	31.7
vs Sector	-100.1%
vs Industry	-100.1%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	ARMISTICE CAPITAL, LLC ($248010.00)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Medical Equipment
CEO	John L. Erb
Employees	38
Country	US
IPO Date	2012-02-16

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.